NCT00006455 - Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99) | Biotech Hunter

Enrollment

885

Participants

Timeline

Start Date

November 26, 1999

Primary Completion Date

January 12, 2009

Study Completion Date

September 3, 2020

Conditions

Lymphoma

Interventions

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

dexamethasone

DRUG

doxorubicin hydrochloride

DRUG

etoposide

DRUG

ifosfamide

DRUG

leucovorin calcium

DRUG

methotrexate

DRUG

therapeutic hydrocortisone

DRUG

vinblastine sulfate

Trial Locations (10)

35128

Azienda Ospedaliera di Padova, Padua

46010

Hospital Clinico Universitario de Valencia, Valencia

A-1090

St. Anna Children's Hospital, Vienna

B-3000

U.Z. Gasthuisberg, Leuven

F-94805

Institut Gustave Roussy, Villejuif

D-35385

Kinderklinik, Giessen

2504 AM

Dutch Childhood Leukemia Study Group, The Hague

S-171 76

Karolinska University Hospital - Huddinge, Stockholm

CH-8032

University Children's Hospital, Zurich

CB2 2QQ

Addenbrooke's Hospital, Cambridge

All Listed Sponsors

lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER